ClinicalTrials.gg
CompletedNCT01578577NAMESUpdated Jun 28, 2019Results posted

Northwestern University and Access Community Health Network Medication Education Study

An interventional study of EHMI and Nurse Educator + EHMI in Hypertension, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-06-28.

Sponsored by Northwestern University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
920
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Many patients have difficulty performing routine medication management tasks. Individuals with limited literacy are at high risk for these problems. The overall study objective is to rigorously evaluate two primary care-based medication therapy management strategies that leverage an electronic health record (EHR) to promote patient understanding, medication reconciliation, medication adherence and disease control among hypertensive patients at safety net clinics.

Read the detailed description

Medication therapy management (MTM) has been described as a set of procedures that include: medication review, assembly of a personal medication record, development of action plans, intervention when necessary, and follow-up. However, evidence showing the effectiveness of general MTM interventions is scant. MTM has often been performed separately from patients' usual sources of care (i.e., at pharmacies). This could limit its effectiveness since medication-related concerns would be discussed by clinicians who are not aware of the regimen intended by patients' prescribers. Cost is another barrier to widespread use of MTM.

Health information technology in primary care could be leveraged to assist with MTM tasks. The investigators have field tested low literacy MTM tools embedded within an EHR to 1) activate patients to review medications, 2) automate the provision of plain language, medication information, and 3) provide print tools to help patients engage providers, and consolidate their regime. These tools were developed with patient, physician, and pharmacist feedback.

For this study, the investigators combine tools to address the range of MTM tasks. In aggregate, the study refers to this as an Electronic health record-based Health literacy Medication therapy management Intervention, or 'EHMI'. The investigators will evaluate the effects of this approach among patients with uncontrolled hypertension treated in federally qualified health centers (FQHCs). This may be a relatively low-cost strategy ideal for safety net practices that use EHRs and whose patients may be at greater risk for limited literacy. It is also possible that the EHMI strategy may not result in a significant change. Therefore, the investigators will also evaluate using a nurse educator to help patients utilize EHMI tools, provide brief counseling, and track progress.

This three-arm, clinic-randomized, controlled trial conducted within a network of FQHCs will evaluate the EHMI and EHMI + Nurse Educator interventions compared to usual care. Recruited patients will be followed for 12 months. The investigators will test the impact of these two strategies on blood pressure levels, with an anticipated power to detect a 4 mm Hg difference in systolic blood pressure as the primary outcome. The investigators will also assess the impact on diastolic blood pressure, as well as HbA1c and LDL cholesterol control in the subgroup with diabetes. The investigators will determine the interventions' effects on: 1) medication understanding, 2) discrepancies, and 3) adherence. The investigators will specifically examine intervention effects among groups with different literacy levels. The investigators will also assess the fidelity and cost of the interventions to guide future dissemination efforts.

02

Conditions studied

  • Hypertension

Keywords

  • Medication Therapy Management
  • Hypertension
  • Health Literacy
  • Medication Reconciliation
  • Medication Adherence
03

In context

Hypertension

6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.

This study's enrollment of 920 is above the median of 90 across 5,095 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,420 studies on the registry; 199 are open to participants now.

Of its 103 completed or terminated interventional studies of FDA-regulated products, 75 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age is 18 years or older
  • at least 3 medications are prescribed by their physician
  • standardized mean blood pressure measurement ≥130 mm Hg systolic or ≥ 80 mm Hg diastolic if they are diabetic or mean blood pressure measurement ≥ 135 mm Hg systolic or ≥ 85 mm Hg diastolic if they are not
  • a Mini-Cog Exam score of ≥ 3
  • the patient is the person primarily responsible for administering their medication
  • the patient does not intend to move or change their usual source of medical care during the next year.

Exclusion criteria

Exclusion Criteria:

  • the patient's usual source of medical care is not a participating ACCESS Community Health Center
  • is non-English language speaking
  • does not meet mean blood pressure criteria
  • has a Mini-Cog Exam score of \< 3
  • is not the person primarily responsible for administering medication
  • intends to move or change their usual source of medical care during the next year.
  • Is not prescribed at least 3 medications
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
920 participants (actual)

Study arms

  • No intervention
    Standard Care

    This arm will serve as a control group and will not receive any intervention.

  • Experimental
    EHMI

    Electronic Health Record-based Health Literacy Medication Therapy Management Intervention (EHMI)arm consists of multiple components, all leveraged by the Epic EHR platform (Verona, WI). The EHMI intervention 1) activates patients to review their medication list and identify any adherence-related concerns, 2) automates a process for providing plain language, patient-centered print medication information for new and refilled prescriptions, and 3) provides additional print tools to help patients more effectively engage their providers, consolidate their regimen, and generally promote safe use and adherence.

    Behavioral: EHMI

  • Experimental
    Nurse Educator + EHMI

    Behavioral: Nurse Educator + EHMI

Interventions

  • BehavioralEHMI

    The EHMI intervention consists of multiple components, all leveraged by the Epic EHR platform (Verona, WI). The EHMI intervention 1) activates patients to review their medication list and identify any adherence-related concerns, 2) automates a process for providing plain language, patient-centered print medication information for new and refilled prescriptions, and 3) provides additional print tools to help patients more effectively engage their providers, consolidate their regimen, and generally promote safe use and adherence.

  • BehavioralNurse Educator + EHMI

    This intervention is a combination of the use of a nurse educator and the EHMI tools described in the EHMI intervention arm. A nurse educator perform the following: 1) perform medication and medical record review 2)assess adherence and medication problems 3) provide counseling to promote safe and effective medication use 4) follow-up with patients after their visit to confirm they have filled all prescriptions, and can accurately teach back their medicine regimen, 5) communicate with prescribing physician when problems are identified.

06

What researchers measure

Primary outcomes

  1. Systolic Blood Pressure

    The primary outcome is the systolic blood pressure measured approximately one year after the baseline interview is conducted.

    Time frame: one year

Secondary outcomes

  1. Effectiveness of the Electronic Health Record-based Health Literacy Medication Therapy Management Strategy (EHMI), With and Without a Nurse Educator, Compared to Standard Care.

    This will be assessed by measuring patient medication understanding, medication reconciliation, adherence, and health outcomes (diastolic blood pressure, and among the diabetic subgroup Hemoglobin A1c \<8.0 and LDL Cholesterol \<100). Reported here: HbA1c \<8 at 12 months. Full secondary outcomes have been published. Persell SD, Karmali KN, MD, Lazar D, Friesema EM, Lee JY, Rademaker A, Kaiser D, Eder M, French DD, Brown T, Wolf MS. Effect of electronic health record-based medication support and nurse-led medication therapy management on hypertension and medication self-management: a randomized clinical trial. JAMA Intern Med. 2018;178:1069-1077.

    Time frame: Baseline, 3 months, 6 months, 12 months

  2. Effects of These Strategies by Patients' Literacy Skills

    We will measure how the effects of the interventions vary based on the participants' literacy levels. SBP at 12 months reported below.

    Time frame: Baseline, 3 months, 6 months,12 months

07

Results

Posted Jun 28, 2019

Participant flow

Participant flow — Overall Study
MilestoneStandard CareEHMINurse Educator + EHMI
Started305302313
Completed254262278
Not completed514035

Outcome measures

PrimarySystolic Blood Pressure

The primary outcome is the systolic blood pressure measured approximately one year after the baseline interview is conducted.

Time frame:
one year
Reported as:
Mean · mm Hg
Systolic Blood Pressure
mm HgStandard CareEHMINurse Educator + EHMI
Systolic Blood Pressure134.5 ± 20.4141.7 ± 22.1134.6 ± 19.9
SecondaryEffectiveness of the Electronic Health Record-based Health Literacy Medication Therapy Management Strategy (EHMI), With and Without a Nurse Educator, Compared to Standard Care.

This will be assessed by measuring patient medication understanding, medication reconciliation, adherence, and health outcomes (diastolic blood pressure, and among the diabetic subgroup Hemoglobin A1c \<8.0 and LDL Cholesterol \<100). Reported here: HbA1c \<8 at 12 months. Full secondary outcomes have been published. Persell SD, Karmali KN, MD, Lazar D, Friesema EM, Lee JY, Rademaker A, Kaiser D, Eder M, French DD, Brown T, Wolf MS. Effect of electronic health record-based medication support and nurse-led medication therapy management on hypertension and medication self-management: a randomized clinical trial. JAMA Intern Med. 2018;178:1069-1077.

Time frame:
Baseline, 3 months, 6 months, 12 months
Reported as:
Count of participants · Participants
Effectiveness of the Electronic Health Record-based Health Literacy Medication Therapy Management Strategy (EHMI), With and Without a Nurse Educator, Compared to Standard Care.
ParticipantsStandard CareEHMINurse Educator + EHMI
Effectiveness of the Electronic Health Record-based Health Literacy Medication Therapy Management Strategy (EHMI), With and Without a Nurse Educator, Compared to Standard Care.614864
SecondaryEffects of These Strategies by Patients' Literacy Skills

We will measure how the effects of the interventions vary based on the participants' literacy levels. SBP at 12 months reported below.

Time frame:
Baseline, 3 months, 6 months,12 months
Reported as:
Mean · mm Hg
Effects of These Strategies by Patients' Literacy Skills
mm HgStandard Care Likely Limited Health LiteracyEHMI Likely Limited Health LiteracyNurse Educator + EHMI Likely Limted Health LiteracyStandard Care Possibly Limited Health LiteracyEHMI Possibly Limited Health LiteracyNurse Educator + EHMI Possibly Limited Health LiteracyStandard Care Likely Adequate Health LiteracyEHMI Likely Adequate Health LiteracyNurse Educator + EHMI Likely Adequate Health Literacy
Effects of These Strategies by Patients' Literacy Skills135.5 ± 20.7141.7 ± 20133.8 ± 18.8138.4 ± 22.4138.4 ± 22.4132.2 ± 19.4135.5 ± 20.1148.1 ± 25.7138.9 ± 21.5

Adverse events

Collected over 12 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard Care—0/305 (0%)0/305 (0%)
EHMI—0/302 (0%)0/302 (0%)
Nurse Educator + EHMI—0/313 (0%)0/313 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Standard CareEHMINurse Educator + EHMITotal
Mean53 ± 9.553.6 ± 9.751.6 ± 9.552.7 ± 9.6
Sex: Female, Male
Sex: Female, Male(Participants)Standard CareEHMINurse Educator + EHMITotal
Female183175187545
Male718791249
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Standard CareEHMINurse Educator + EHMITotal
Hispanic or Latino1042337
Not Hispanic or Latino237250233720
Unknown or Not Reported782237
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Standard CareEHMINurse Educator + EHMITotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American234243215692
White13114165
More than one race0000
Unknown or Not Reported782237
08

Study locations

1 site
  • ACCESS Community Health Network
    Chicago, Illinois 60661, United States
09

References and documents

Publications

  • Persell SD, Karmali KN, Lazar D, Friesema EM, Lee JY, Rademaker A, Kaiser D, Eder M, French DD, Brown T, Wolf MS. Effect of Electronic Health Record-Based Medication Support and Nurse-Led Medication Therapy Management on Hypertension and Medication Self-management: A Randomized Clinical Trial. JAMA Intern Med. 2018 Aug 1;178(8):1069-1077. doi: 10.1001/jamainternmed.2018.2372. PubMed 29987324 ↗
  • Persell SD, Eder M, Friesema E, Connor C, Rademaker A, French DD, King J, Wolf MS. EHR-based medication support and nurse-led medication therapy management: rationale and design for a three-arm clinic randomized trial. J Am Heart Assoc. 2013 Oct 24;2(5):e000311. doi: 10.1161/JAHA.113.000311. PubMed 24157649 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2012, a primary completion of Jun 2016 and a completion of Jun 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Jun 2019, 3 years after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 12, 2012
First posted
Apr 17, 2012
Start
Apr 2012
Primary completionActual
Jun 2016
CompletionActual
Jun 2016
Results first posted
Jun 28, 2019
Last update
Jun 28, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01578577
Responsible party
Stephen Persell, MD, MPH (Assistant Professor, Northwestern University) — Principal investigator
First posted
Apr 17, 2012
Start date
Apr 2012
Primary completion
Jun 2016
Completion
Jun 2016
Results posted
Jun 28, 2019
Last update
Jun 28, 2019

Study contacts

Stephen Persell, MD, MPH
principal investigator · Northwestern University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion